Lam JO, Hou CE, Hojilla JC, et al
Scientific and Official Sources PubChem: BPC-157 sequence-related identity, molecular formula and calculated molecular weight United States FDA: 2026 briefing document for BPC-157 free peptide and BPC-157 acetate ClinicalTrials.gov: BPC-157 safety and pharmacokinetics Phase I registry record Sikiric and colleagues: BPC-157, L-arginine and nitric-oxide-system research Lojo and colleagues: experimental use of BPC-157, L-NAME and L-arginine as separate agents McGuire and colleagues: review of BPC-157 evidence and safety uncertainties United States FDA: safety concerns involving certain bulk substances, including BPC-157 MHRA: borderline products and how to tell if a product is a medicine Human Medicines Regulations 2012: Regulation 279 World Anti-Doping Agency: 2026 Prohibited List
Skin Research and Technology, 5 (3), 195-207
Pharmaceutics 2023 (microbiostatic vs microbicidal agents
"AngIV-analog dihexa rescues cognitive impairment and recovers memory in the APP/PS1 mouse via the PI3K/AKT signaling pathway."Brain sciences11.11 (2021): 1487
Its best to draw each dose just before use
